1. | Zou, Jianjun: 17 articles (06/2022 - 01/2019) |
2. | Wang, Quanren: 11 articles (06/2022 - 01/2019) |
3. | Huang, Jing: 11 articles (02/2022 - 01/2018) |
4. | Xiong, Jianping: 9 articles (12/2021 - 10/2018) |
5. | Yang, Qing: 8 articles (05/2022 - 01/2018) |
6. | Chen, Zhendong: 8 articles (12/2021 - 01/2020) |
7. | Gu, Kangsheng: 7 articles (06/2022 - 01/2020) |
8. | Qin, Shukui: 7 articles (12/2021 - 01/2020) |
9. | Wang, Linna: 7 articles (12/2021 - 01/2020) |
10. | Cheng, Ying: 6 articles (06/2022 - 01/2021) |
1. | apatinib
|
2. | Immune Checkpoint Inhibitors
|
3. | lenvatinib
|
4. | anlotinib
|
5. | Cisplatin (Platino)
|
6. | Sorafenib (BAY 43-9006)
|
7. | Paclitaxel (Taxol)
|
8. | Decitabine
|
9. | Capecitabine (Xeloda)
|
10. | pembrolizumab
|
1. | Drug Therapy (Chemotherapy)
|
2. | Therapeutics
|
3. | Radiotherapy
|
4. | Immunotherapy
|
5. | Neoadjuvant Therapy
|